Skip to main content
. Author manuscript; available in PMC: 2015 Jun 1.
Published in final edited form as: Heart Rhythm. 2014 May 13;11(6):925–932. doi: 10.1016/j.hrthm.2014.03.006

Figure 3.

Figure 3

Kaplan-Meier curves for stroke or non-CNS embolism in patients randomized to rivaroxaban versus warfarin, grouped by amiodarone use at baseline (vs. no AAD). AAD=antiarrhythmic drug; CNS=central nervous system.